Fisher & Paykel Healthcare Corporation Limited logo

SPH Notice - Hyperion Asset Management Limited

Substantial Holder Notice12 November 2025FPHHealthcare

1
Disclosure of ceasing to have substantial holding

Section 279, Financial Markets Conduct Act 2013

To NZX and ASX

and

To Fisher & Paykel Healthcare Corp. Ltd

Date this disclosure made:12/11/2025

Date last disclosure made:20/10/2025

Date on which substantial holding ceased:10/11/2025

Substantial product holder(s) giving disclosure

Full name(s):Hyperion Asset Management Limited

Summary of previous substantial holding

Class of quoted voting products: ordinary share

Summary for Hyperion Asset Management Limited For last disclosure,—

(a) total number held in class: 30,432,527

(b) total in class: 587,262,856

(c) total percentage held in class: 5.182%

For current holding after ceasing to have substantial holding,—

(a) total number held in class: 29,251,816

(b) total in class: 587,262,856

(c) total percentage held in class: 4.981%

Details of transactions and events giving rise to ceasing of substantial holding

Details of the transactions or other events requiring disclosure: Refer to Annexure A

Additional information

Address(es) of substantial product holder(s): Level 19, 307 Queen St, Brisbane QLD

4000, Australia

Contact details: Terence Kwong, terence.kwong@pinnacleinvestment.com, +61 2

8970 7748

Certification


I, Te rence Kwong, certify that, to the best of my knowledge and belief, the information

contained in this disclosure is correct and that I am duly authorised to make this disclosure

by all persons for whom it is made.

Annexure A
Date of Change

Person whose

relevant interest

changed

Nature of

change

Consideration

given in relation

to change (NZD)

Number of

securities

affected

Person's

votes

affected

Class of

securities

21/10/2025

Hyperion Asset

Management

Purchase

168,621.30$ 4,752 4,752

ORDINARY

FULLY PAID

22/10/2025

As abovePurchase

160,228.25$ 4,573 4,573

ORDINARY

FULLY PAID

23/10/2025

As abovePurchase

1,409,522.70$ 39,625 39,625

ORDINARY

FULLY PAID

27/10/2025

As abovePurchase

154,716.59$

4,386 4,386

ORDINARY

FULLY PAID

28/10/2025

As abovePurchase

4,187,665.73$

118,136 118,136

ORDINARY

FULLY PAID

03/11/2025

As above

Sale

27,591,258.64-$ 756,206- 756,206-

ORDINARY

FULLY PAID

06/11/2025

As aboveSale

17,963,079.78-$ 475,651- 475,651-

ORDINARY

FULLY PAID

10/11/2025

As aboveSale

4,625,159.89-$ 120,326- 120,326-

ORDINARY

FULLY PAID

Terence Kwong

Company Secretary

Date: 12/11/2025

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.